Diclofenac Potentiates Sorafenib-Based Treatments of Hepatocellular Carcinoma by Enhancing Oxidative Stress

Sorafenib is the first developed systemic treatment for advanced forms of hepatocellular carcinoma, which constitutes the most frequent form of primary liver cancers and is a major global health burden. Although statistically significant, the positive effect of sorafenib on median survival remains m...

Descripción completa

Detalles Bibliográficos
Autores principales: Duval, Adrian Paul, Troquier, Laetitia, de Souza Silva, Olga, Demartines, Nicolas, Dormond, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827164/
https://www.ncbi.nlm.nih.gov/pubmed/31569821
http://dx.doi.org/10.3390/cancers11101453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827164/
https://www.ncbi.nlm.nih.gov/pubmed/31569821
http://dx.doi.org/10.3390/cancers11101453

Ejemplares similares